Recombinant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Is Heterogeneous
- 1 January 1996
- journal article
- basic science
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 11 (1) , 20-30
- https://doi.org/10.1097/00042560-199601010-00003
Abstract
Summary: Recombinant wild type (wt) and T215Y HIV-1 reverse transcriptase (RT) were isolated using three methods designated A, B, and C. The three samples of wt RT were kinetically indistinguishable with respect to dTTP turnover on poly(rA) · p(dT)10. However, whereas the kinetic constants for dTTP and AZTTP for both T215Y B and T215Y C were similar to those of wt protein, T215Y A exhibited a twofold increase in Km value for dTTP and a 13-fold increase in Ki value for AZTTP with respect to wt protein purified in the same manner. We further investigated this observation by studying the denaturation of wt RT by urea. The urea denaturation curves monitored by fluorescence and circular dichroism spectroscopy were not coincident with the denaturation curve monitored by enzyme activity and yielded Cm values (the concentration of urea at which 50% of the protein is denatured) of 4.1 and 2.0 M urea, respectively. The noncoincidence of the transition curves reflects two separable, sequential, noncooperative conformational changes in the molecule: (a) from a catalytically active to an inactive conformation, and (b) from a catalytically inactive to a denatured, unfolded conformation. We therefore used denaturation as detected by changes in enzyme activity to compare the conformational stability of the three samples of wt and T215Y RT A, B, and C. The Cm values for T215Y RT did not differ from those of the respective wt; however, differences in Cm values were noted depending on how the protein was isolated. This suggested that the heterogeneity of the recombinant RT was due to small differences in conformation at or near the active site.Keywords
This publication has 21 references indexed in Scilit:
- Human immunodeficiency virus type 1 (HIV‐1) recombinant reverse transcriptaseFEBS Letters, 1994
- Characterization of the dimerization process of HIV‐1 reverse transcriptase heterodimer using intrinsic protein fluorescenceFEBS Letters, 1993
- Folding and stability of trp aporepressor from Escherichia coliBiochemistry, 1990
- Denaturation/Refolding of Purified Recombinant HIV Reverse Transcriptase Yields Monomeric Enzyme with High Enzymatic ActivityAIDS Research and Human Retroviruses, 1990
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989
- HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysisBiochemistry, 1988
- Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAVScience, 1986
- Comparison of the rates of inactivation and conformational changes of creatine kinase during urea denaturationBiochemistry, 1984
- Solute perturbation of protein fluorescence. Quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ionBiochemistry, 1971
- Correction of fluorescence spectra and measurement of fluorescence quantum efficiencyThe Analyst, 1960